A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

NCT02336503 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperhidrosis

Interventions

DRUG: BBI-4000 Gel, 5%
DRUG: BBI-4000 Gel, 10%
DRUG: BBI-4000 Gel, 15%
DRUG: Vehicle

Sponsor

Botanix Pharmaceuticals